人类免疫缺陷病毒抗体初筛阳性确证结果分析及化学发光法检测抗体吸光度值/临界值灰区范围的合理性探究

Analysis of the confirmation results of human immunodeficiency virus antibody preliminary screening positive samples and investigation of rationality of gray zone for detecting antibody signal-to-cutoff ratio value by chemiluminescence method

  • 摘要:
    目的 分析人类免疫缺陷病毒(HIV)抗体初筛阳性确证结果及化学发光法检测抗体吸光度值/临界值(S/CO值)灰区范围的合理性。
    方法 收集184例HIV抗体筛查阳性标本。采用免疫印迹法(WB)及病毒核酸测定法进行确证,观察确证结果及条带分布。采用受试者工作特征(ROC)曲线预测最佳临界值,分析HIV抗体S/CO值灰区设置的合理性。
    结果 184例HIV抗体筛查阳性标本中,经化学发光法初筛153例(83.15%), 经胶体金法初筛31例(16.85%)。男性(57.07%)、年龄在40岁以上(75.00%)的HIV抗体初筛阳性病例占比高于女性及其他年龄段病例。WB补充试验发现,共101例(54.89%)病例确证为HIV-1抗体阳性, 56例(30.43%)病例确证为HIV-1抗体阴性, 27例(14.67%)病例为HIV-1抗体不确定。27例中, 1例经核酸检测为阳性(化学发光法初筛抗体S/CO值: 5.60), 其余26例为阴性。化学发光法、胶体金法与WB补充试验的阳性符合率分别为65.36%、3.23%, 差异有统计学意义(χ2=40.191, P < 0.05)。27例HIV-1抗体不确定病例经核酸检测载量发现, 1例病例WB带型为P24+gp160, 核酸检测该病例为阳性。不确定样本带型分布中, P24出现率最高(74.07%), 其后依次是P66(11.11%)、gp160(7.41%)和P17(3.70%)、gp41(3.70%)。ROC曲线预测HIV抗体S/CO最佳临界值为5.15, 曲线下面积(AUC)为0.904, 敏感度与特异度分别为83.30%、76.40%, 95%CI为0.861~0.948。HIV抗体初筛阳性病例的WB检测带型与确证结果之间具有较好相关性(P < 0.05), 其中P24带型与确证结果之间的相关性最高(r=0.910)。
    结论 HIV抗体初筛阳性病例中存在一定的假阳性, 采用WB实验能进行有效排查。此外,基于本实验检测平台设置化学发光法检测HIV抗体S/CO值灰区范围为1.00~5.15, 其具有较高的敏感度。

     

    Abstract:
    Objective To analyze the confirmation results of initial screening positive for human immunodeficiency virus (HIV) antibodies and to investigate the rationality of the gray zone for the signal-to-cutoff (S/CO) ratio values obtained by chemiluminescence assay.
    Methods A total of 184 specimens with positive HIV antibody screening results were collected. Confirmation was conducted using the Western blot (WB) method and viral nucleic acid testing, and the confirmation outcomes and band distribution were observed. The receiver operating characteristic (ROC) curve was employed to predict the optimal cutoff value, and the rationality of S/CO values in establishing a gray zone for HIV antibody was analyzed.
    Results Among the 184 HIV antibody screening positive samples, 153(83.15%) were initially screened by chemiluminescence, and 31 (16.85%) were screened by colloidal gold method. Male cases (57.07%) and those aged 40 years or older (75.00%) had higher proportion of initial screening positivity than females and other age groups. Supplemental WB testing revealed that 101 (54.89%) cases were confirmed as HIV-1 antibody positive, 56(30.43%) were negative, and 27(14.67%) were indeterminate. Of the 27 indeterminate cases, one was confirmed positive by NAT (initial S/CO value by chemiluminescence5.60), while the remaining 26 were negative. The positive agreement rates between chemiluminescence, colloidal gold and supplemental WB testing were 65.36% and 3.23%, respectively, with statistically significant difference (χ2=40.191, P < 0.05). Among 27 cases with indeterminate HIV-1 antibody results, upon further nucleic acid testing for viral load, one case exhibited WB banding pattern of P24+gp160, and the nucleic acid load confirmed this case as positive. In the distribution of band patterns among indeterminate samples, P24 had the highest occurrence (74.07%), followed by P66 (11.11%), gp160 (7.41%) as well as P17 and gp41 (both 3.70%). The ROC curve predicted the optimal S/CO cutoff value to be 5.15, with an area under the curve (AUC) of 0.904, sensitivity and specificity of 83.30% and 76.40%, respectively, and 95%CI of 0.861 to 0.948. There was a good correlation between the WB band patterns and confirmation results for initial screening positive cases (P < 0.05), with the highest correlation found for the P24 band (r=0.910).
    Conclusion There is a certain rate of false positives among HIV antibody initial screening positive cases, and effective screening can be achieved through WB testing. Additionally, based on the current testing platform, the gray zone for HIV antibody S/CO values in the chemiluminescence assay is set at 1.00 to 5.15, which exhibits high sensitivity.

     

/

返回文章
返回